临床路径在腹腔镜胆囊切除术住院患者中的应用与评价

摘要

Objective To evaluate the effect of Laparoscopic cholecystectomy of a new clinical pathway on healthcare quality. Methods Thirty patients underwent original clinical pathway for in-patient in West China Hospital. Thirty patients underwent new clinical pathway for in-patitent in West China Hospital. I compared the hospitalization costi in-hospital days, and stay time before operation of in-patient between these two groups. Results Compared with in-hospital days of the two group, the new clinical pathway group with original clinical pathway group decreased 1. 83days(P< 0. 05). The stay time before operation decreased 2. 22 days(P<0. 05). The hospitalization cost decreased 2255. 23 RMB (P>0. 05). Conclusion The new clinical pathway is practicality which can improve the bed turnover rate effectively, decrease patients' stay time before operation and decreased of hospitalization cost.%目的 探讨实施临床路径对新型腹腔镜胆囊切除术患者临床效益的影响.方法 纳入因胆囊结石合并慢性胆囊炎住院行腹腔镜切除术患者60例,均分为临床路径组30例(优化组)和非临床路径组30例(普通组),临床路径组采用改进临床路径法,非临床路径组实施常规法,观察比较两组患者平均住院日、平均住院费用、住院手术并发症等指标,统计两组间有无差异.结果 纳入临床路径患者住院费用比未纳入者下降2255.23元,平均住院日缩短1.83天,术前等待时间缩短2.22天.结论 新型临床路径具有良好的实用性,能够在保证医疗安全的情况下提高各项医疗指标,提高医疗效益,解决病人看病贵的问题,值得进一步推广应用.